Myrenfors P G, Eriksson T, Sandsted C S, Sjöberg G
Swedish Poison Information Centre, Karolinska Hospital, Stockholm.
J Intern Med. 1993 Feb;233(2):113-5. doi: 10.1111/j.1365-2796.1993.tb00662.x.
Moclobemide is a recently introduced short-acting, selective and reversible monoamine oxidase inhibitor, type A, with few and mild side-effects at therapeutic doses. Fifteen reported cases of moclobemide overdose were studied in detail and are presented here. While pure mechanism overdosage seems benign, a combination with tricyclic antidepressants may result in serious poisoning even when the moclobemide overdose is modest.